表纸
市场调查报告书

呼吸系统疾病治疗药的全球市场:未来预测 (到2022年)

Respiratory Diseases Drugs Global Market Report 2020-30: Covid 19 Implications and Growth

出版商 The Business Research Company 商品编码 531335
出版日期 内容资讯 英文
商品交期: 2-3个工作天内
价格
呼吸系统疾病治疗药的全球市场:未来预测 (到2022年) Respiratory Diseases Drugs Global Market Report 2020-30: Covid 19 Implications and Growth
出版日期: 2020年05月19日内容资讯: 英文
简介

本报告提供全球呼吸系统疾病治疗药的市场结构、趋势相关分析,市场的主要特征、结构,及整体市场规模、成长率趋势预测,各类型、各地区、主要国家详细趋势,与主要宏觀经济指标的对比,主要企业的简介,近几年的市场主要趋势等调查。

第1章 摘要整理

第2章 分析结构

第3章 呼吸系统疾病治疗药市场特征

第4章 呼吸系统疾病治疗药市场:各产品分析

  • 主要的产品/服务
  • 主要的功能与差异化要素
  • 开发中的产品

第5章 呼吸系统疾病治疗药市场供应链

  • 供应链
  • 流通
  • 最后客户

第6章 呼吸系统疾病治疗药市场:客户资讯

  • 客户方面的偏好
  • 最终用途市场规模和成长率

第7章 呼吸系统疾病治疗药市场:趋势与策略

第8章 呼吸系统疾病治疗药:市场规模与成长率

  • 市场规模
  • 市场成长率:成果值 (以金额为准)
    • 推动市场要素
    • 阻碍市场要素
  • 市场成长率:预测值 (以金额为准)
    • 推动市场要素
    • 阻碍市场要素

第9章 呼吸系统疾病治疗药的市场:各地区的分析

  • 市场规模的最新值:各地区 (以金额为准,2018年)
  • 市场规模的成果值、预测值:各地区 (以金额为准,2014~2022年)
  • 成长率、市场占有率比较:各地区

第10章 呼吸系统疾病治疗药的市场:各市场区隔分析

  • 各市场区隔的市场规模:成果值、预测值 (以金额为准,2014~2022年)
    • 抗气喘药/COPD治疗药
    • 感冒药

第11章 呼吸系统疾病治疗药的市场:主要指标

  • 市场规模占GDP比率 (全球,2014~2022年)
  • 平均每人平均支出额 (全球,2014~2022年)

第12章 亚太地区的呼吸系统疾病治疗药的市场

  • 市场概要
  • 市场规模的最新值:各国 (以金额为准,2018年)
  • 市场规模的成果值、预测值:各国 (2014~2022年)
  • 市场成长率、市场占有率:各国比较 (2014~2022年)
  • 相关指标
    • 每人支出额 (2014~2022年)
    • 气喘盛行率 (2018年)
  • 市场规模:各类型 (以金额为准,2014~2022年)
  • 各国分析
    • 中国
    • 澳洲
    • 香港
    • 印度
    • 印尼
    • 日本
    • 马来西亚
    • 纽西兰
    • 菲律宾
    • 新加坡
    • 韩国
    • 泰国
    • 越南

第13章 西欧的呼吸系统疾病治疗药的市场

  • 各国分析
    • 奥地利
    • 比利时
    • 丹麦
    • 芬兰
    • 法国
    • 德国
    • 爱尔兰
    • 义大利
    • 荷兰
    • 挪威
    • 葡萄牙
    • 西班牙
    • 瑞典
    • 瑞士
    • 英国

第14章 东欧的呼吸系统疾病治疗药的市场

  • 各国分析
    • 捷克
    • 波兰
    • 罗马尼亚
    • 俄罗斯

第15章 北美的呼吸系统疾病治疗药的市场

  • 各国分析
    • 加拿大
    • 墨西哥
    • 美国

第16章 南美的呼吸系统疾病治疗药的市场

  • 各国分析
    • 阿根廷
    • 巴西
    • 智利
    • 哥伦比亚
    • 秘鲁
    • 委内瑞拉

第17章 中东的呼吸系统疾病治疗药的市场

  • 各国分析
    • 沙乌地阿拉伯
    • 以色列
    • 土耳其
    • 阿拉伯联合大公国 (UAE)

第18章 非洲的呼吸系统疾病治疗药的市场

  • 各国分析
    • 埃及
    • 奈及利亚
    • 南非

第19章 呼吸系统疾病治疗药市场竞争情形

  • 竞争市场概要
  • 市场占有率
  • 企业简介
    • GlaxosmithKline Plc
    • AstraZeneca Plc
    • Merck & Co
    • Novartis AG
    • Johnson & Johnson

第20章 呼吸系统疾病治疗药市场上主要企业合并、收购 (M&A)

第21章 市场背景情况:医药品市场

  • 市场特征
  • 市场规模、成长率的变化与预测:各领域 (以金额为准,2014~2022年)
  • 市场规模:各地区 (以金额为准,2018年)
  • 市场规模:各地区 (2014~2022年)
  • 市场规模:各类型 (以金额为准,2014~2022年)

第22章 建议

  • 对成长国的建议
  • 对成长领域的建议
  • 成长策略的建议

第23章 附录

第24章 著作权、免责声明

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

‘Respiratory Diseases Drugs Global Market Report 2020-30: Covid 19 Implications and Growth ’ from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for respiratory diseases drugs which play a critical role in the treatment of patients with Covid 19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the respiratory diseases drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Respiratory Diseases Drugs Market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider respiratory diseases drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The respiratory diseases drugs market section of the report gives context. It compares the respiratory diseases drugs market with other segments of the respiratory diseases drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, respiratory diseases drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: GlaxosmithKline Plc; AstraZeneca Plc; Merck & Co; Novartis AG; Johnson & Johnson

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, respiratory diseases drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Respiratory Diseases Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Respiratory Diseases Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Respiratory Diseases Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Respiratory Diseases Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Respiratory Diseases Drugs Market Trends And Strategies

8. Respiratory Diseases Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Respiratory Diseases Drugs Market Regional Analysis

  • 9.1. Global Respiratory Diseases Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region

10. Respiratory Diseases Drugs Market Segmentation

  • 10.1. Global Respiratory Diseases Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

  • 10.2. Global Respiratory Diseases Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Respiratory Diseases Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Respiratory Diseases Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Respiratory Diseases Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Respiratory Diseases Drugs Market Metrics

  • 11.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Respiratory Diseases Drugs Market

  • 12.1. Asia-Pacific Respiratory Diseases Drugs Market Overview
  • 12.2. Asia-Pacific, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Respiratory Diseases Drugs Market Metrics
    • 12.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Asia-Pacific Countries
    • 12.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Asia-Pacific Countries
  • 12.6. Asia-Pacific Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis
    • 12.7.1. China Respiratory Diseases Drugs Market
      • 12.7.1.1. China Respiratory Diseases Drugs Market Overview
      • 12.7.1.2. China Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Respiratory Diseases Drugs Market
      • 12.7.2.1. Australia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Respiratory Diseases Drugs Market
      • 12.7.3.1. Hong Kong Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Respiratory Diseases Drugs Market
      • 12.7.4.1. India Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Respiratory Diseases Drugs Market
      • 12.7.5.1. Indonesia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Respiratory Diseases Drugs Market
      • 12.7.6.1. Japan Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Respiratory Diseases Drugs Market
      • 12.7.7.1. Malaysia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Respiratory Diseases Drugs Market
      • 12.7.8.1. New Zealand Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Respiratory Diseases Drugs Market
      • 12.7.9.1. Philippines Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Respiratory Diseases Drugs Market
      • 12.7.10.1. Singapore Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Respiratory Diseases Drugs Market
      • 12.7.11.1. South Korea Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Respiratory Diseases Drugs Market
      • 12.7.12.1. Thailand Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Respiratory Diseases Drugs Market
      • 12.7.13.1. Vietnam Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Respiratory Diseases Drugs Market

  • 13.1. Western Europe Respiratory Diseases Drugs Market Overview
  • 13.2. Western Europe, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Respiratory Diseases Drugs Market Metrics
    • 13.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Western Europe Countries
    • 13.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Western Europe Countries
  • 13.6. Western Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Respiratory Diseases Drugs Market: Country Analysis
    • 13.7.1. Austria Respiratory Diseases Drugs Market
      • 13.7.1.1. Austria Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Respiratory Diseases Drugs Market
      • 13.7.2.1. Belgium Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Respiratory Diseases Drugs Market
      • 13.7.3.1. Denmark Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Respiratory Diseases Drugs Market
      • 13.7.4.1. Finland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Respiratory Diseases Drugs Market
      • 13.7.5.1. France Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Respiratory Diseases Drugs Market
      • 13.7.6.1. Germany Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Respiratory Diseases Drugs Market
      • 13.7.7.1. Ireland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Respiratory Diseases Drugs Market
      • 13.7.8.1. Italy Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Respiratory Diseases Drugs Market
      • 13.7.9.1. Netherlands Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Respiratory Diseases Drugs Market
      • 13.7.10.1. Norway Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Respiratory Diseases Drugs Market
      • 13.7.11.1. Portugal Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Respiratory Diseases Drugs Market
      • 13.7.12.1. Spain Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Respiratory Diseases Drugs Market
      • 13.7.13.1. Sweden Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Respiratory Diseases Drugs Market
      • 13.7.14.1. Switzerland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Respiratory Diseases Drugs Market
      • 13.7.15.1. UK Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Respiratory Diseases Drugs Market

  • 14.1. Eastern Europe Respiratory Diseases Drugs Market Overview
  • 14.2. Eastern Europe, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Respiratory Diseases Drugs Market Metrics
    • 14.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Eastern Europe Countries
    • 14.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Eastern Europe Countries
  • 14.6. Eastern Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Respiratory Diseases Drugs Market,
      • 14.7.1.1. Czech Republic Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Respiratory Diseases Drugs Market
      • 14.7.2.1. Poland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Respiratory Diseases Drugs Market
      • 14.7.3.1. Romania Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Respiratory Diseases Drugs Market
      • 14.7.4.1. Russia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Respiratory Diseases Drugs Market

  • 15.1. North America Respiratory Diseases Drugs Market Overview
  • 15.2. North America, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Respiratory Diseases Drugs Market Metrics
    • 15.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, North America Countries
    • 15.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, North America Countries
  • 15.6. North America Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Respiratory Diseases Drugs Market: Country Analysis
    • 15.7.1. Canada Respiratory Diseases Drugs Market
      • 15.7.1.1. Canada Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Respiratory Diseases Drugs Market
      • 15.7.2.1. Mexico Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Respiratory Diseases Drugs Market
      • 15.7.3.1. USA Respiratory Diseases Drugs Market Overview
      • 15.7.3.2. USA Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Respiratory Diseases Drugs Market

  • 16.1. South America Respiratory Diseases Drugs Market Overview
  • 16.2. South America, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Respiratory Diseases Drugs Market Metrics
    • 16.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, South America Countries
    • 16.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, South America Countries
  • 16.6. South America Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Respiratory Diseases Drugs Market: Country Analysis
    • 16.7.1. Argentina Respiratory Diseases Drugs Market
      • 16.7.1.1. Argentina Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Respiratory Diseases Drugs Market
      • 16.7.1.1. Brazil Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Respiratory Diseases Drugs Market
      • 16.7.3.1. Chile Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Respiratory Diseases Drugs Market
      • 16.7.4.1. Colombia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Respiratory Diseases Drugs Market
      • 16.7.5.1. Peru Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Respiratory Diseases Drugs Market
      • 16.7.6.1. Venezuela Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Respiratory Diseases Drugs Market

  • 17.1. Middle East Respiratory Diseases Drugs Market Overview
  • 17.2. Middle East, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Respiratory Diseases Drugs Market Metrics
    • 17.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Middle East Countries
    • 17.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Middle East Countries
  • 17.6. Middle East Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Respiratory Diseases Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Respiratory Diseases Drugs Market
      • 17.7.1.1. Saudi Arabia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Respiratory Diseases Drugs Market
      • 17.7.2.1. Israel Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Respiratory Diseases Drugs Market
      • 17.7.3.1. Turkey Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Respiratory Diseases Drugs Market
      • 17.7.4.1. UAE Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Respiratory Diseases Drugs Market

  • 18.1. Africa Respiratory Diseases Drugs Market Overview
  • 18.2. Africa, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Respiratory Diseases Drugs Market Metrics
    • 18.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Africa Countries
    • 18.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Africa Countries
  • 18.6. Africa Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Respiratory Diseases Drugs Market: Country Analysis
    • 18.7.1. Egypt Respiratory Diseases Drugs Market
      • 18.7.1.1. Egypt Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Respiratory Diseases Drugs Market
      • 18.7.2.1. Nigeria Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Respiratory Diseases Drugs Market
      • 18.7.3.1. South Africa Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Respiratory Diseases Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. GlaxosmithKline Plc
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. AstraZeneca Plc
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Merck & Co
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Novartis AG
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Johnson & Johnson
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Respiratory Diseases Drugs Market In 2023- Growth Countries
  • 22.2. Global Respiratory Diseases Drugs Market In 2023- Growth Segments
  • 22.3. Global Respiratory Diseases Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer